2017
Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review
Bazan IS, Mensah KA, Rudkovskaia AA, Adonteng-Boateng PK, Herzog EL, Buckley L, Fares WH. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review. Respiratory Medicine 2017, 134: 42-46. PMID: 29413506, DOI: 10.1016/j.rmed.2017.11.020.BooksConceptsPulmonary arterial hypertensionConnective tissue disease-associated pulmonary arterial hypertensionConnective tissue diseasePulmonary hypertensionSSc-PAHArterial hypertensionSystemic sclerosisTissue diseaseElevated left ventricular filling pressurePathobiology of PAHLeft ventricular filling pressureMixed connective tissue diseasePre-capillary pulmonary hypertensionWorld Health Organization classificationSetting of lupusSetting of sclerodermaPulmonary vascular resistanceRight heart failureVentricular filling pressurePAH etiologyPathophysiologic criteriaSLE-PAHVascular resistanceProgressive diseaseSystemic lupus
2015
Lupus‐Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition
Mensah KA, Yadav R, Trow TK, Brunet CM, Fares WH. Lupus‐Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition. Case Reports In Medicine 2015, 2015: 328435. PMID: 26229536, PMCID: PMC4503546, DOI: 10.1155/2015/328435.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPulmonary arterial hypertensionSystemic lupus erythematosusVariable courseRight-sided heart pressuresSevere pulmonary arterial hypertensionLife-threatening symptomsLong-term outcomesEvidence-based therapiesEffective treatment approachArterial hypertensionMultiorgan dysfunctionSLE flareHeart pressuresLupus erythematosusPrompt recognitionCirculatory shockSame patientTreatment approachesYoung womenLevel interventionsSymptomsSignificant improvementReportErythematosusHypertension